● Recruiting

Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)

Condition: Plaque Psoriasis · Sponsor: Bristol-Myers Squibb

PhasePhase 3

Planned participants3040

Who can joinAll sexes, 40 Years to no upper limit

Healthy volunteersNo

About this study

A study to evaluate the long-term safety of Deucravacitinib versus Ustekinumab in participants with psoriasis

This description comes directly from the study's public registry record.

Talk to the study team

BMS Clinical Trials Contact Center www.BMSClinicalTrials.com · 855-907-3286 · Clinical.Trials@bms.com

First line of the email MUST contain NCT # and Site #.

Always discuss trial participation with your own doctor first.

Locations (394)

Local Institution - 0088	Birmingham, Alabama, United States	Not Yet Recruiting
Medical Dermatology Specialists - Phoenix	Phoenix, Arizona, United States	Recruiting
Saguaro Dermatology - Phoenix	Phoenix, Arizona, United States	Recruiting
Omni Dermatology	Phoenix, Arizona, United States	Recruiting
Alliance Dermatology	Phoenix, Arizona, United States	Recruiting
Local Institution - 0322	Scottsdale, Arizona, United States	Withdrawn
Local Institution - 0188	Scottsdale, Arizona, United States	Withdrawn
Scottsdale Clinical Trials	Scottsdale, Arizona, United States	Recruiting
Omni Dermatology	Tempe, Arizona, United States	Recruiting
Clinical Trials Institute of Northwest Arkansas	Fayetteville, Arkansas, United States	Recruiting
Northwest Arkansas Clinical Trials Center (NWACTC), PLLC	Rogers, Arkansas, United States	Recruiting
California Dermatology & Clinical Research Institute	Encinitas, California, United States	Recruiting

+ 382 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07116967